|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.60 EUR | +4.62% |
|
-1.16% | +158.31% |
| 07-03 | Genfit soars on news of U.S. reimbursement for a product |  |
| 07-03 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 680M 778M 628M 577M 1.09B 74.87B 1.11B 7.49B 2.94B 36.6B 2.92B 2.86B 126B | P/E 2026 * |
71.5x | P/E 2027 * | 90.3x |
|---|---|---|---|---|---|
| Enterprise Value | 629M 720M 580M 534M 1.01B 69.25B 1.03B 6.93B 2.72B 33.85B 2.7B 2.64B 117B | EV / Sales 2026 * |
6.28x | EV / Sales 2027 * | 4.95x |
| Free-Float |
86.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +4.62% | ||
| 1 week | -1.16% | ||
| Current month | +28.30% | ||
| 1 month | +40.35% | ||
| 3 months | +45.45% | ||
| 6 months | +151.62% | ||
| Current year | +158.31% |
| 1 week | 12.76 |  | 14.26 |
| 1 month | 9 | | 14.32 |
| Current year | 5.05 | | 14.32 |
| 1 year | 3.05 | | 14.32 |
| 3 years | 2.62 | | 14.32 |
| 5 years | 2.62 | | 14.32 |
| 10 years | 2.62 | | 35.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 15/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 21/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 26/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 15/06/2017 | |
| Director/Board Member | 54 | 14/09/1999 | |
| Director/Board Member | 58 | 15/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 03-04 | Fiscal year | Chief Operating Officer | 7,083 | 0.0142% | ||
| 03-04 | Sell | Chief Operating Officer | 11,250 | 0.0225% | ||
| 03-04 | Fiscal year | Chief Operating Officer | 11,250 | 0.0225% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.62% | -1.16% | +297.89% | +271.58% | 744M | |
| -0.17% | +1.47% | +3.16% | +6.80% | 50.35B | |
| -0.29% | -2.81% | +387.81% | +591.82% | 39.32B | |
| -0.49% | +1.48% | +31.16% | -6.46% | 34.69B | |
| +1.53% | +3.11% | +15.41% | +58.54% | 34.08B | |
| +1.68% | -0.62% | +3.30% | +27.34% | 26.63B | |
| +1.13% | -3.11% | - | - | 16.49B | |
| -1.29% | -0.52% | +69.24% | +117.60% | 15.31B | |
| +0.43% | +3.34% | +14.96% | +17.46% | 13.8B | |
| +2.45% | +3.99% | +18.20% | -30.12% | 12.87B | |
| Average | +0.96% | +0.71% | +93.46% | +117.17% | 24.43B | |
| Weighted average by Cap. | +0.41% | +0.78% | +82.64% | +122.79% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 100M 115M 92.43M 84.97M 161M 11.03B 164M 1.1B 433M 5.39B 430M 421M 18.58B | 124M 142M 114M 105M 199M 13.65B 203M 1.37B 536M 6.67B 533M 521M 23B |
| Net income | 22.88M 26.17M 21.1M 19.4M 36.76M 2.52B 37.39M 252M 98.86M 1.23B 98.27M 96.11M 4.24B | 6.8M 7.78M 6.27M 5.77M 10.93M 748M 11.11M 74.89M 29.38M 366M 29.21M 28.57M 1.26B |
| Net Debt | -51.12M -58.47M -47.16M -43.35M -82.13M -5.63B -83.54M -563M -221M -2.75B -220M -215M -9.48B | -66.17M -75.69M -61.04M -56.11M -106M -7.28B -108M -729M -286M -3.56B -284M -278M -12.27B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | €13.60 | +4.62% | 288,369 |
| 14/07/26 | €13.00 | -3.70% | 284,717 |
| 13/07/26 | €13.50 | -1.75% | 610,685 |
| 10/07/26 | €13.74 | -0.29% | 345,417 |
| 09/07/26 | €13.78 | +0.15% | 426,540 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
